We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
“New drugs and vaccines are being brought to the market for the first time in public health programs in settings where the safety monitoring and regulatory systems need strengthening,” said MHRA’s CEO Ian Hudson. Read More